(News 24h) – Russian vaccine was approved by Iran to import Sputnik V co-production in Iran.
Iran’s Food and Drug Administration spokesperson Kianoush Jahanpour this week said Iran had granted import permits and co-production of Russia’s COVID-19 vaccine, Sputnik V, in an urgent effort to combat a pandemic. bridge.
|Iran licenses the Russian vaccine for COVID-19.|
Sputnik V vaccine will be imported into Iran in the form of a single-dose vial and a 5-dose vial.
Other vaccines made in India, China and Russia are also being evaluated by the FDA, IRNA reported, Jahanpour said.
On January 29, Iranian Ambassador to Russia Kazem Jalali also told the IRNA news agency about the above information.
“After registering Sputnik V in Iran on January 29, Iran and Russia signed an agreement on the purchase and joint production of vaccines,” said Jalali.
According to the Iranian diplomat, the agreement is reached with the Russian Direct Investment Fund (RDIF) and the first batch of vaccine will be shipped to Iran before February 4.
Ambassador Jalali noted that a delegation of Iran’s Health Ministry will visit Russia in the next 10 days to discuss the production of Sputnik V vaccine in Iran.
Iran’s Health Minister Saeed Namaki said that Iran is relying on four channels of COVID-19 vaccine distribution: purchased directly from abroad, purchased under the COVAX distribution program of the World Health Organization (WHO), combined production cooperation with a foreign company, and domestic vaccine production.
“The clinical trial with the Coviran Barekat vaccine is also going well and the Razi Institute is getting a license for clinical trials. Another company will also receive a license to test human vaccines next week” – Minister of Medicine explains Iran.
Mahmoud Vaezi, head of the Iranian Presidential Office, also said that Iran is currently in talks with Russia, China and India for about two months to buy the vaccine and that talks with Russia are significantly faster.
Besides US economic sanctions, Iran also faces a global pandemic crisis. During a news conference on Jan. 29, Health Ministry spokesman Sima-Sadat Lari confirmed 6,573 new COVID-19 infections, bringing the total to 1,405,414.
She added that 1,196,374 patients have so far recovered, but 3,990 are still in critical condition.
Within 24 hours, 71 patients lost their lives, bringing the total number of deaths to 57,807.
In developments related to Russia’s Sputnik V vaccine, the Russian Direct Investment Fund (RDIF) and health officials announced on January 29 that Guinea became the second African country to license the Sputnik vaccine circulation. V of Russia, after Algeria. According to an unnamed source, the West African state is currently in talks to buy an additional 2 million doses of the Sputnik V vaccine.
In addition to the two African countries mentioned above, the Sputnik V vaccine is currently licensed for use in Venezuela, Serbia, Argentina and the Palestinian territories.
The head of RDIF, Kirill Dmitriev Vaccine Sputnik V of this country, will be approved for domestic use in 25 countries over the next few weeks. According to him, the vaccine is currently registered in 14 countries and in the next few weeks, the number will be more than 25 countries.
Serbia has also received an additional 40,000 doses of the Sputnik V vaccine from Russia. Serbian Minister of Innovation, Nenad Popovic stated: “Russian vaccines have received great attention all over the world. Serbia is one of the countries that are interested in Sputnik V and that we have received this batch of vaccines. the relationship between the two countries is very close “.
According to Mr. Popovic, Russian experts are expected to come to Serbia on February 11 and coordinate with their Serbian colleagues at the Torlak Institute to assess the conditions to be able to quickly launch Sputnik V production in Serbia. . To date, Serbia has vaccinated more than 420,000 out of a total of 4.1 million people, since the start of the vaccination process on December 24, 2020, making the country second in Europe in billion. rate of vaccinated citizens on the total population.